Clin2
NCT07858773Possibly a fitNot yet recruiting

Preventing wheezing after a first chest infection

Lower Respiratory Tract Infection (LRTI)Recurrent Wheezing

Treatments studied

Part of Immune system & allergy, Lungs & breathing clinical trials.

This trial tests whether a medication can prevent wheezing after a baby's first chest infection, especially for those with risk factors. It may help reduce future breathing problems.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
486 people
Ages
3 months to 2 years
Study type
Interventional

Who can take part

  • Your baby is between 3 and 24 months old
  • Your baby has a current chest infection with cough or trouble breathing, plus fast breathing or chest pulling
  • The infection started within the last 7 days
  • Your baby has never had a chest infection or wheezing before
  • Your baby has at least one risk factor for recurrent wheezing (like smoke exposure, family allergies, or early birth)
  • Your baby is not taking certain steroid medications and has no other chronic illness

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03889743Recruiting· Phase 4
Steroid treatment to help prevent asthma after a first wheezing illness

This trial studies whether an early steroid treatment can lower the chance that children will go on to develop asthma after their first severe “wheezing” episode caused by a rhinovirus (a common cold virus). If you qualify, the goal is to prevent future asthma rather than just treat the current episode.

Turku
NCT05063149Recruiting· Phase 3
Bacterial lysate for preventing breathing infections in preterm infants

This study tests a medicine called a bacterial lysate, which might help prevent respiratory infections and wheezing in babies born early. It could reduce sickness and breathing problems in the first year of life.

Rotterdam, South Holland
NCT07675252Not yet recruiting· Phase 4
Inhaled steroid for wheezing in infants under 2

This trial tests whether a nebulized (inhaled mist) steroid medicine called fluticasone propionate helps reduce wheezing in infants under 2 years old. It aims to see if this treatment is safe and effective for babies who are hospitalized with wheezing.

NCT05444699Recruiting· Phase 4
Oral steroid for cold-related wheezing in children under 2

This trial tests whether a short course of oral prednisolone (an anti-inflammatory steroid) helps young children under 2 who have wheezing triggered by a rhinovirus cold. It aims to see if steroid treatment can improve symptoms after an emergency visit.

Kokkola
NCT06580600Recruiting
Precision medicine for steroids in preschool wheeze

This study tests if giving oral steroids (medicine to reduce airway swelling) only when needed based on a child's own biology can help preschool children with wheezing. It aims to find the best treatment for each child, avoiding unnecessary medicine.

Belfast, NI
NCT02496468Recruiting
Study for children with wheezing or asthma symptoms

This study follows children with wheezing (in younger kids) or doctor-diagnosed asthma (in older kids). It aims to better understand asthma and related breathing problems and how they develop over time.

Cologne

Hear when a new Lower Respiratory Tract Infection (LRTI) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.